Literature DB >> 1764778

Plasma neopterin as an adjunct to C-reactive protein in assessment of infection.

J Sheldon1, P G Riches, N Soni, E Jurges, M Gore, G Dadian, J R Hobbs.   

Abstract

C-reactive protein (CRP) concentrations are increased in plasma in people with inflammatory conditions and bacterial infections. Plasma neopterin concentrations are increased in people with bacterial septicemias, viral infections, and graft vs host disease. Plasma concentrations of CRP and neopterin were measured daily in 21 bone-marrow transplant (BMT) patients, 64 patients in intensive-care units (ICU), and 12 patients with squamous cell carcinoma of the head and neck (HN). In the BMT patients, plasma neopterin measurements in addition to CRP measurements allowed infectious episodes to be distinguished from graft vs host disease. In the ICU patients, increased concentrations of CRP were not specific for infection and the additional plasma neopterin measurements did not improve this specificity. In all three patient groups, the derivation of a neopterin/CRP ratio was of no clinical use. These three groups of patients showed patterns of CRP and neopterin concentrations characteristic of their underlying diseases, the BMT patients with the immunological activation of graft vs host disease showed predominantly increased concentrations of plasma neopterin, ICU patients with infectious and inflammatory conditions had increased concentrations of both CRP and neopterin in plasma, and the HN group with localized inflammation showed increased plasma concentrations of CRP without increases in neopterin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1764778

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Association of detectable cytomegalovirus (CMV) DNA in monocytes rather than positive CMV IgG serology with elevated neopterin levels in community-dwelling older adults.

Authors:  Sean X Leng; Huifen Li; Qian-Li Xue; Jing Tian; Xi Yang; Luigi Ferrucci; Neal Fedarko; Linda P Fried; Richard D Semba
Journal:  Exp Gerontol       Date:  2011-04-13       Impact factor: 4.032

2.  Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat.

Authors:  Monique E Spencer; Alka Jain; Amy Matteini; Brock A Beamer; Nae-Yuh Wang; Sean X Leng; Naresh M Punjabi; Jeremy D Walston; Neal S Fedarko
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-05-17       Impact factor: 6.053

3.  Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection.

Authors:  R Brunkhorst; O K Eberhardt; M Haubitz; F M Brunkhorst
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

Review 4.  Anaemia of cancer: an overview of mechanisms involved in its pathogenesis.

Authors:  H Z W Grotto
Journal:  Med Oncol       Date:  2007-09-02       Impact factor: 3.064

5.  Serum procalcitonin for differentiating bacterial infection from disease flares in patients with autoimmune diseases.

Authors:  Kowoon Joo; Won Park; Mie-Jin Lim; Seong-Ryul Kwon; Jiyeol Yoon
Journal:  J Korean Med Sci       Date:  2011-09-01       Impact factor: 2.153

6.  Neopterin Counters Vascular Inflammation and Atherosclerosis.

Authors:  Remina Shirai; Kengo Sato; Tomoyuki Yamashita; Maho Yamaguchi; Taisuke Okano; Kaho Watanabe-Kominato; Rena Watanabe; Taka-Aki Matsuyama; Hatsue Ishibashi-Ueda; Shinji Koba; Youichi Kobayashi; Tsutomu Hirano; Takuya Watanabe
Journal:  J Am Heart Assoc       Date:  2018-02-02       Impact factor: 5.501

7.  Infection markers as predictors of Bacteremia in an Intensive Care Unit: A prospective study.

Authors:  Pinar Sen; Tuna Demirdal; Salih Atakan Nemli; Ilknur Vardar; Mehmet Kizilkaya; Atilla Sencan; Huriye Erbak Yilmaz
Journal:  Pak J Med Sci       Date:  2018 Nov-Dec       Impact factor: 1.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.